Immunomodulatory effect of mushrooms and their bioactive compounds in cancer: A comprehensive review

Manash Pratim Pathak1, Kalyani Pathak2, Riya Saikia2

  • 1Faculty of Pharmaceutical Science, Assam down town University, Panikhaiti, Guwahati 781026, Assam, India.

Insights

Mushrooms, rich in bioactive compounds, show promising immunomodulatory and anti-cancer effects, offering a safer, natural alternative to conventional therapies for cancer patients. This review explores their mechanisms and potential in drug development.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology
  • Natural Product Chemistry

Background:

  • Cancer remains a significant global health challenge, with current treatments facing limitations due to compromised immunity and high costs.
  • Emerging therapies like nano-formulations and immunotherapy show promise but require further clinical validation and accessibility improvements.
  • Natural sources are increasingly explored for cancer treatments due to their potential for higher safety margins and multitarget efficacy.

Purpose of the Study:

  • To review the molecular mechanisms of cancer development and conventional treatment strategies.
  • To highlight recent breakthroughs in anti-cancer drug development, including novel therapeutic approaches.
  • To comprehensively examine the anti-cancer properties of selected mushroom species and their bioactive compounds.

Main Methods:

  • Literature review of scientific databases focusing on cancer genesis, pharmacology, and natural product research.
  • Analysis of studies on mushroom's immunomodulatory and anti-cancer activities.
  • Investigation of research on mushroom-derived bioactive compounds and their mechanisms of action.
  • Review of studies on metallic nanoparticles loaded with mushroom extracts for cancer therapy.

Main Results:

  • Mushrooms possess significant immunomodulatory effects, impacting various immune cells crucial for cancer defense.
  • Selected mushroom species exhibit potent anti-cancer activities through diverse molecular mechanisms.
  • Bioactive phytoconstituents from mushrooms demonstrate therapeutic potential against cancer.
  • Metallic nanoparticles loaded with mushroom extracts show enhanced anti-cancer efficacy in preclinical studies.

Conclusions:

  • Mushrooms represent a valuable natural resource for developing novel, safe, and effective anti-cancer therapies.
  • Their multitarget pharmacological actions and immunomodulatory properties make them promising candidates for cancer treatment, especially for immunocompromised patients.
  • Further research into mushroom-derived compounds and nano-formulations could lead to innovative cancer drug development.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
643
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
59